1. Treatment With Ibritumomab Tiuxetan Radioimmunotherapy in Patients With Rituximab-Refractory Follicular Non-Hodgkin’s Lymphoma
   Thomas E. Witzig et al, 2002, Journal of Clinical Oncology CrossRef
2. Site-specific Conjugation of 6 DOTA Chelators to a CA19-9-targeting scFv-Fc Antibody for Imaging and Therapy
   Li-An Chen et al, 2023, Journal of Medicinal Chemistry CrossRef
3. Incidental Uptake of In-111 Ibritumomab Tiuxetan in Surgically Treated Fracture
   Hidenari Hirata et al, 2011, Advances in Molecular Imaging CrossRef